ARCHIVES

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

Fox Chase, UCLA, U. Washington Win Neutron Contracts

October 5, 1979